AI药物研发遭遇病毒学检验：为何呼吸道病毒聚合酶会突破基准
AI Drug Discovery Gets a Virology Check: Why Respiratory Virus Polymerases Break the Benchmarks
报道
- AI药物研发遭遇病毒学检验：为何呼吸道病毒聚合酶会突破基准 AI Drug Discovery Gets a Virology Check: Why Respiratory Virus Polymerases Break the Benchmarks Bioengineer.org · · 首发